» Articles » PMID: 12895690

Improved Cognitive Function in Postmenopausal Women After 12 Weeks of Consumption of a Soya Extract Containing Isoflavones

Overview
Publisher Elsevier
Date 2003 Aug 5
PMID 12895690
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

We previously reported that a high soya diet improved memory and frontal lobe function in young volunteers, and since soya isoflavones are agonists at oestrogen receptors, they may improve these functions in postmenopausal women. Thirty-three postmenopausal women (50-65 years) not receiving conventional hormone replacement therapy (HRT) were randomly allocated in a double-blind parallel study to receive a soya supplement (60 mg total isoflavone equivalents/day) or placebo for 12 weeks. They received a battery of cognitive tests and completed analogue rating scales of mood and sleepiness, and a menopausal symptoms questionnaire before the start of treatment and then after 12 weeks of treatment. Those receiving the isoflavone supplement showed significantly greater improvements in recall of pictures and in a sustained attention task. The groups did not differ in their ability to learn rules, but the isoflavone supplement group showed significantly greater improvements in learning rule reversals. They also showed significantly greater improvement in a planning task. There was no effect of treatment on menopausal symptoms, self-ratings of mood, bodily symptoms or sleepiness. Thus, significant cognitive improvements in postmenopausal women can be gained from 12 weeks of consumption of a supplement containing soya isoflavones that are independent of any changes in menopausal symptoms, mood or sleepiness.

Citing Articles

Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects.

Faysal M, Dehbia Z, Zehravi M, Sweilam S, Akiful Haque M, Kumar K Neurochem Res. 2024; 49(8):1926-1944.

PMID: 38822985 DOI: 10.1007/s11064-024-04177-x.


Long-term effects of an egg-protein hydrolysate on cognitive performance and brain vascular function: a double-blind randomized controlled trial in adults with elevated subjective cognitive failures.

Adams M, Mensink R, Plat J, Joris P Eur J Nutr. 2024; 63(6):2095-2107.

PMID: 38703228 PMC: 11377360. DOI: 10.1007/s00394-024-03394-y.


Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential.

Al Amin M, Dehbia Z, Nafady M, Zehravi M, Kumar K, Akiful Haque M Mol Cell Biochem. 2024; 480(1):43-73.

PMID: 38568359 DOI: 10.1007/s11010-023-04922-w.


Natural flavonoids as potential therapeutics in the management of Alzheimer's disease: a review.

Nguyen-Thi P, Vo T, Pham T, Nguyen T, Van Vo G 3 Biotech. 2024; 14(3):68.

PMID: 38357675 PMC: 10861420. DOI: 10.1007/s13205-024-03925-8.


Nutritional interventions in treating menopause-related sleep disturbances: a systematic review.

Polasek D, Santhi N, Alfonso-Miller P, Walshe I, Haskell-Ramsay C, Elder G Nutr Rev. 2023; 82(8):1087-1110.

PMID: 37695299 PMC: 11233886. DOI: 10.1093/nutrit/nuad113.